Prevalence of hepatitis C in drug users in Flanders: determinants and geographic differences

Matheï, Cathy; Robaeys, Geert; Damme, Pierre Van; Buntinx, Frank; Verrando, Rita

doi:10.1017/s0950268804002973

Cited by 27 publications

(24 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…We found 28 published reports that met our criteria (Allwright et al, 2000;Baozhang et al, 1997;Broers et al, 1998;Chang et al, 1999;Denis et al, 2000;Feldman et al, 2000;Fuller et al, 2004;Galperim et al, 2004;Garten et al, 2004;Gyarmathy et al, 2002;Harsch et al, 2000;Hershow et al, 1998;Howe et al, 2005;Koblin et al, 2003;Lai et al, 2001;Maayan et al, 1994;Mathei et al, 2005;Njoh et al, 1997;Nyamathi et al, 2002;Quaglio et al 2003a;Quaglio et al 2003b;Santana Rodriguez et al, 1998;Shrestha et al, 1998;Strasfeld et al, 2003;Tortu et al, 2001;Tortu et al, 2004;Van Ameijden et al, 1993;Ward et al, 2000). One report included two separate studies, both of which were included (Tortu et al, 2001) and which appear in Table 1 in two separate rows; two reports were by the same author and indicated the same overall seroprevalence and sample size, therefore we counted this as one study (Quaglio et al 2003a(Quaglio et al & 2003b.…”

Section: Study Characteristicsmentioning

confidence: 89%

Non-injection drug use and Hepatitis C Virus: A systematic review

Scheinmann

Hagan

Leluţiu-Weinberger

et al. 2007

Drug and Alcohol Dependence

168

121

View full text Add to dashboard Cite

This systematic review examined the evidence on the prevalence of the Hepatitis C virus (HCV) in non-injecting drug users (NIDUs) who sniff, smoke or snort drugs such as heroin, cocaine, crack or methamphetamine. The search included studies published from January 1989 to January 2006. Twenty-eight eligible studies were identified and the prevalence of HCV in these NIDU populations ranged from 2.3% to 35.3%. There was substantial variation in study focus and in the quality of the NIDU data presented in the studies. The results of our systematic review suggested that there are important gaps in the research of HCV in NIDUs. We identified a problem of study focus; much of the research did not aim to study HCV in users of non-injection drugs. Instead, NIDUs were typically included as a secondary research concern, with a principal focus on the problem of transmission of HCV in IDU populations. Despite methodological issues, HCV prevalence in this population is much higher than in a non-drug using population, even though some IDUs might have inadvertently been included in the NIDU samples. These studies point to a real problem of HCV in NIDU populations, but the causal pathway to infection remains unclear.

show abstract

Section: Study Characteristicsmentioning

confidence: 89%

Non-injection drug use and Hepatitis C Virus: A systematic review

Scheinmann

Hagan

Leluţiu-Weinberger

et al. 2007

Drug and Alcohol Dependence

168

121

View full text Add to dashboard Cite

show abstract

“…Among the 310 drug users in Antwerp, prevalence of anti-HCV antibody was 71% and in Limburg in Belgium was 46% (Matheï et al, 2005). The Hepatitis C European Network for C-operative Research (HENCORE) group had reported the prevalence of 80% hepatitis C among intravenous drug users (IVDU) (Touzet et al, 2000).…”

Section: Discussionmentioning

confidence: 99%

Prevalence of Hepatitis C virus infections among the general population of Buner, Khyber Pakhtunkhwa, Pakistan

et al. 2016

View full text Add to dashboard Cite

Introduction: In the current study, prevalence of hepatitis C virus and its routes of transmission were determined in district Buner, Khyber Pakhtunkhwa, Pakistan. Methods: Total 230 blood samples for HCV were collected from 7 tehsils of District Buner. Diaspot rapid HCV strips manufactured by Diaspot diagnostic USA were used for the detection of HCV-Ab in the blood. Results: Out of 230 blood samples collected from patients, 158 were found positive for HCV infection. Of the 158 positive cases, 102 (64.55%) were male and 56 (35.45%) were female patients. The high rate of Hepatitis C infection was found in the age group of 41-50 years that was 68 (29.56%), followed by age group of 20-30 years that was 60 (26.08%), 31-40 years that was 54 (23.47%). The lowest infection was found in age group above 70 years. Conclusion: It is concluded from the study that such high proportion of hepatitis C prevalence will result in high rate of mortality and morbidity in the area. Possible steps are required for the prevention and cure of such viral infections.

show abstract

“…Instead, intravenous drug abuse has become the main cause of HCV transmission in developed areas such as Europe and the USA [9,10] . The estimated prevalence of HCV infection among injecting drug users (IDUs) is between 30 and 80% [11][12][13] . The number of IDUs in Japan is steadily increasing, particularly among young people, according to the data published by the Ministry of Health, Labour and Welfare.…”

Section: Features Of Recent Hcv Transmission In Japanmentioning

confidence: 99%

Changing Trends in Hepatitis C Infection over the Past 50 Years in Japan

Chung

Ueda

Kudo³

2010

Intervirology

149

137

View full text Add to dashboard Cite

In Japan, hepatocellular carcinoma (HCC) is the fourth leading cause of death in males and the fifth in females. Hepatitis C virus (HCV) is a major cause of HCC in Japan, with 70% of cases being HCV related. HCV genotype 1b, the most prevalent subtype in Japan, started to spread in the 1930s among injecting drug users (IDUs) during and after World War II or through medical procedures such as blood transfusion and use of contaminated syringes. The prevalence of HCV infection is much lower in the current younger generation compared with that in the older generation, particularly those aged >55 years (0.1–0.2% vs. ≧ 2%). Therefore, the total number of patients with HCV infection is estimated to decrease, even though sporadic HCV transmission is mainly seen among young IDUs. Of note, HCV genotype 2 seems to be spreading among IDUs, but the response to antiviral therapy in these patients seems to be better than that in older patients, irrespective of the genotype. Although the number of patients who die because of HCC has steadily increased over the last 50 years, the incidence of HCC is now decreasing, mainly because of the decreased prevalence of HCV-related HCC.

show abstract

Prevalence of hepatitis C in drug users in Flanders: determinants and geographic differences

Cited by 27 publications

References 23 publications

Non-injection drug use and Hepatitis C Virus: A systematic review

Non-injection drug use and Hepatitis C Virus: A systematic review

Prevalence of Hepatitis C virus infections among the general population of Buner, Khyber Pakhtunkhwa, Pakistan

Changing Trends in Hepatitis C Infection over the Past 50 Years in Japan

Contact Info

Product

Resources

About